# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-124895
Filing Date
2018-04-20
Accepted
2018-04-20 16:13:34
Documents
4
Period of Report
2018-05-31
Effectiveness Date
2018-04-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | d563018ddef14a.htm | DEF 14A | 1263220
2 | GRAPHIC | g563018g70t93.jpg | GRAPHIC | 220809
3 | GRAPHIC | g563018g83b21.jpg | GRAPHIC | 84883
4 | GRAPHIC | g563018g95s09.jpg | GRAPHIC | 213235
| Complete submission text file | 0001193125-18-124895.txt |  | 1979419

Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 18766817
SIC: 2834 Pharmaceutical Preparations